Central nervous system disease in patients with macrophagic myofasciitis

Brain

Volumn 124, Issue 5, 2001, Pages 974-983

  Authier, François Jérôme ^a,b,c   Cherin, P ^l   Creange, A ^a   Bonnotte, B ^e   Ferrer, X ^f   Abdelmoumni, A ^g   Ranoux, D ^d   Pelletier, J ^h   Figarella Branger, D ⁱ   Granel, B ^j   Maisonobe, T ^l   Coquet, M ^k   Degos, J D ^c   Gherardi, R K ^a,b  

^a FACULTÉ DE MÉDECINE   (France)

^b HÔpital Henri Mondor AP HP   (France)

^c HENRI MONDOR HOSPITAL   (France)

^d CENTRE HOSPITALIER SAINTE ANNE   (France)

^e HÔPITAL DU BOCAGE   (France)

^f Hop du Haut Leveque   (France)

^g CENTRE HOSPITALIER SUD FRANCILIEN   (France)

^h AP HM Timone   (France)

ⁱ Service d'Anatomie Pathologique   (France)

^j TIMONE HOSPITAL   (France)

^k HÔPITAL PELLEGRIN   (France)

^l NONE

more..

Author keywords

Inflammatory myopathy; Macrophage; Multiple sclerosis; Myofasciitis; Vaccine

Indexed keywords

ALUMINUM DERIVATIVE; TETANUS TOXOID; VACCINE;

ADULT; ARTICLE; BEHAVIOR DISORDER; BLADDER DYSFUNCTION; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATING DISEASE; EVOKED RESPONSE; FEMALE; FRANCE; HEPATITIS B VIRUS; HUMAN; MACROPHAGE; MACROPHAGIC MYOFASCIITIS; MALE; MULTIPLE SCLEROSIS; MUSCLE BIOPSY; MYALGIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIODIC ACID SCHIFF STAIN; PRIORITY JOURNAL; SENSORIMOTOR FUNCTION; T LYMPHOCYTE; VISUAL IMPAIRMENT;

EID: 0035010232     PISSN: 00068950     EISSN: None     Source Type: Journal    
DOI: 10.1093/brain/124.5.974     Document Type: Article

References (29)

1. Adams M, Rhyner PA, Day J, DeArmond S, Smuckler EA. Whipple's disease confined to the central nervous system. Ann Neurol 1987; 21: 104-8
2. Authier FJ, Créange A, Maisonobe T, Ranoux D, Abdelmoumni A, Lorcerie B, et al. Central nervous system involvement associated with macrophagic myofasciitis. Neurology 1999; 52 Suppl 2: A449.
3. Balouet G, Baret M, Relyveld E, Ravisse P, Levaditi J. Rôle des antigènes et des substances adjuvantes dans la réponse histologique au cours de granulomes experimentaux ('granulome immunogène'). Ann Anat Pathol (Paris) 1977; 22: 159-70.
4. Banker BQ. Other Inflammatory myopathies. In: Engel AG, Franzini-Armstrong C, editor. Myology. 2nd ed. New York: McGraw-Hill; 1994. p. 1461-86.
5. Cabello A, Ruiz-Falcò ML, Garcia-Peña JJ, Madero S, Ferreiro A, Bàez B, et al. Macrophagic myofasciitis: a new case of non-French origin [abstract]. Neuropathol Appl Neurobiol 1999; 25 Suppl 1: 44.
6. Carpenter S, Karpati G. The pathological diagnosis of specific inflammatory myopathies. [Review]. Brain Pathol 1992; 2: 13-19.
7. Gherardi RK, Coquet M, Chérin P, Authier FJ, Laforêt P, Bélec L, et al. Macrophagic myofasciitis: an emerging entity. Lancet 1998; 352: 347-52.
8. Gherardi RK, Coquet M, Bélec L, Chariot P, Moretto P, Figarella-Branger D, et al. Macrophagic myofasciitis: a reaction to intramuscular injections of aluminium-containing vaccines [abstract]. J Neurol 1999; 246 Suppl 1: I/19.
9. Granel B, Pelletier J, Serratrice J, Swiader L, Pache X, Pellissier JF, et al. Manifestations neurologiques de la myofasciite à macrophages. Rev Med Interne 1999; 20 Suppl 1: 41s.
10. Gray F, Nordmann P. Sarcoidosis. In: Graham DI, Lantos PL, editors. Greenfield's neuropathology. 6th ed. London: Arnold; 1997. p. 145-6.
11. Griffin DE. Monophasic autoimmune inflammatory diseases of the CNS and PNS. [Review]. Res Pub Assoc Res Nerv Ment Dis 1990; 68: 91-104.
12. Gupta RK, Rost BE, Relyveld E, Siber GR. Adjuvant properties of aluminium and calcium compounds. [Review]. Pharm Biotechnol 1995; 6: 229-48.
13. Layzer RB. Muscle pain, cramps, and fatigue. In: Engel AG, Franzini-Armstrong C, editor. Myology. 2nd ed. New York: McGraw-Hill; 1994. p. 1754-68.
14. Louis ED, Lynch T, Kaufmann P, Fahn S, Odel J. Diagnostic guidelines in central nervous system Whipple's disease. Ann Neurol 1996; 40: 561-8.
15. Matthews BW. Neurologic manifestations of sarcoidosis. In: Asbury AK, McKahnn GM, McDonald WI, editor. Diseases of the nervous system. Clinical neurobiology. 2nd ed. Philadelphia: W.B. Saunders; 1992. p. 1531-7.
16. McMahon BJ, Helminiak C, Wainwright RB, Bulkow L, Trimble BA, Wainwright K. Frequency of adverse reactions to hepatitis B vaccine in 43,618 persons. Am J Med 1992; 92: 254-6.
17. Ministère de l'emploi et de la solidarité. Dossier: Le point sur la vaccination contre l'hépatite B. Available from: http:// www.sante.gouv.fr
18. Misbah SA, Ozols B, Franks A, Mapstone N. Whipple's disease without malabsorption: new atypical features. QJM 1997; 90: 765-72.
19. Naschitz JE, Boss JH, Misselevich I, Yeshurun D, Rosner I. The fasciitis-panniculitis syndromes. Clinical and pathologic features. [Review]. Medicine (Baltimore) 1996; 75: 6-16.
20. Navarro C, Rodrìguez D, Willisch A, Fachal C, Teijeiro A, Fernàndez R, et al. Macrophagic myofasciitis. A report of a new Spanish case [abstract]. Neuropathol Appl Neurobiol 1999; 25 Suppl 1: S81.
21. Paty DW, McFarlin DE, McDonald WI. Magnetic resonance imaging and laboratory aids in the diagnosis of multiple sclerosis [editorial]. Ann Neurol 1991; 29: 3-5.
22. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
23. Romanul FC, Radvany J, Rosales RK. Whipple's diseases confined to the brain: a case studied clinically and pathologically. J Neurol Neurosurg Psychiatry 1977; 40: 901-9.
24. Sharma OP. Neurosarcoidosis. A personal perspective based on the study of 37 patients. Chest 1997; 112: 220-8.
25. Swash M, Schwartz MS, Vandenburg MJ, Pollock DJ. Myopathy in Whipple's disease. Gut 1977; 18: 800-4.
26. Tourbah A, Gout O, Liblau R, Lyon-Caen O, Bougniot C, Iba-Zizen MT, et al. Encephalitis after hepatitis B vaccination. Recurrent disseminated encephalitis or MS? Neurology 1999; 53: 396-401.
27. WHO Vaccine Safety Advisory Committee. Macrophagic myofasciitis and aluminium-containing vaccines. Wkly Epidemiol Rec 1999; 74: 337-40.
28. Wroe SJ, Pires M, Harding B, Youl BD, Shorvon S. Whipple's disease confined to the CNS presenting with multiple intracerebral mass lesions. J Neurol Neurosurg Psychiatry 1991; 54: 989-92.
29. Zipp F, Weil JG, Einhaupl KM. No increase in demyelinating diseases after hepatitis B vaccination [letter]. Nat Med 1999; 5: 964-5.